3616-59-9 Usage
General Description
4-(2,2-diethoxyethyl)morpholine is an organic chemical compound that falls under the classification of morpholine compounds. The molecular formula of this substance is C10H21NO3. Its structure comprises a morpholine ring, which is a six-membered ring containing four carbon atoms, one oxygen atom, and one nitrogen atom, attached to a 2,2-diethoxyethyl side chain. This chemical can be used in various applications in the chemical industry due to its unique structure. However, like other chemicals, it should be handled and stored carefully due to potential hazards associated with it. The properties and safety measures regarding this chemical should be detailed in its Material Safety Data Sheet (MSDS).
Check Digit Verification of cas no
The CAS Registry Mumber 3616-59-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,6,1 and 6 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 3616-59:
(6*3)+(5*6)+(4*1)+(3*6)+(2*5)+(1*9)=89
89 % 10 = 9
So 3616-59-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H21NO3/c1-3-13-10(14-4-2)9-11-5-7-12-8-6-11/h10H,3-9H2,1-2H3
3616-59-9Relevant articles and documents
MULTISUBSTITUTED AROMATIC COMPOUNDS AS INHIBITORS OF THROMBIN
-
Paragraph 0297-0298, (2017/12/07)
There are provided inter alia multisubstituted aromatic compounds useful for the inhibition of thrombin, which compounds include substituted pyrazolyl or substituted triazolyl. There are additionally provided pharmaceutical compositions. There are additionally provided methods of treating and preventing a disease or disorder, which disease or disorder is amenable to treatment or prevention by the inhibition of thrombin.
MULTISUBSTITUTED AROMATIC COMPOUNDS AS INHIBITORS OF THROMBIN
-
Page/Page column 78, (2011/10/31)
There are provided inter alia multisubstituted aromatic compounds useful for the inhibition of thrombin, which compounds include substituted pyrazolyl or substituted triazolyl. There are additionally provided pharmaceutical compositions. There are additionally provided methods of treating and preventing a disease or disorder, which disease or disorder is amenable to treatment or prevention by the inhibition of thrombin.
